BIRC5 and pancreatic neoplasm: Its ability to drastically reduce Survivin protein contents in a mutational load-independent fashion enhances TH301 potential to cause PDAC apoptosis and supports its usefulness in novel, promising, and powerful regimens for pancreatic cancer chemotherapy.